Get started
Bluejay Diagnostics, Inc.Bluejay Diagnostics, Inc.Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc.

No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Seasonals

BJDX fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
BJDX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company